{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:53:35Z","timestamp":1785891215280,"version":"3.56.0"},"publisher-location":"New York, NY","reference-count":24,"publisher":"Springer New York","isbn-type":[{"value":"9781493968671","type":"print"},{"value":"9781493968695","type":"electronic"}],"license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1007\/978-1-4939-6869-5_15","type":"book-chapter","created":{"date-parts":[[2017,4,3]],"date-time":"2017-04-03T09:58:42Z","timestamp":1491213522000},"page":"255-267","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Bacteriophage T4 as a Nanoparticle Platform to Display and Deliver Pathogen Antigens: Construction of an Effective Anthrax Vaccine"],"prefix":"10.1007","author":[{"given":"Pan","family":"Tao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sathish B.","family":"Shivachandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venigalla B.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,4]]},"reference":[{"key":"15_CR1","volume-title":"Vaccine protocols","year":"2003","unstructured":"Andrew R, Michael JH, Martin PC (eds) (2003) Vaccine protocols, vol 87, 2nd edn. Humana Press Inc., Totowa, NJ","edition":"2"},{"issue":"15","key":"15_CR2","doi-asserted-by":"publisher","first-page":"7688","DOI":"10.1128\/JVI.00235-06","volume":"80","author":"T Sathaliyawala","year":"2006","unstructured":"Sathaliyawala T et al (2006) Assembly of human immunodeficiency virus (HIV) antigens on bacteriophage T4: a novel in vitro approach to construct multicomponent HIV vaccines. J Virol 80(15):7688\u20137698","journal-title":"J Virol"},{"issue":"7","key":"15_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003495","volume":"9","author":"P Tao","year":"2013","unstructured":"Tao P et al (2013) Mutated and bacteriophage T4 nanoparticle arrayed F1-V immunogens from Yersinia pestis as next generation plague vaccines. PLoS Pathog 9(7):e1003495","journal-title":"PLoS Pathog"},{"key":"15_CR4","doi-asserted-by":"crossref","unstructured":"Tao P, Mahalingam M, Rao VB (2016) Highly effective soluble and bacteriophage T4 nanoparticle plague vaccines against Yersinia pestis. Methods Mol Biol 1403:499\u2013518","DOI":"10.1007\/978-1-4939-3387-7_28"},{"issue":"1","key":"15_CR5","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.virol.2005.10.037","volume":"345","author":"SB Shivachandra","year":"2006","unstructured":"Shivachandra SB et al (2006) In vitro binding of anthrax protective antigen on bacteriophage T4 capsid surface through Hoc-capsid interactions: a strategy for efficient display of large full-length proteins. Virology 345(1):190\u2013198","journal-title":"Virology"},{"issue":"15","key":"15_CR6","doi-asserted-by":"publisher","first-page":"5846","DOI":"10.1073\/pnas.1300867110","volume":"110","author":"P Tao","year":"2013","unstructured":"Tao P et al (2013) In vitro and in vivo delivery of genes and proteins using the bacteriophage T4 DNA packaging machine. Proc Natl Acad Sci U S A 110(15):5846\u20135851","journal-title":"Proc Natl Acad Sci U S A"},{"key":"15_CR7","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/B978-0-12-394621-8.00018-2","volume":"82","author":"LW Black","year":"2012","unstructured":"Black LW, Rao VB (2012) Structure, assembly, and DNA packaging of the bacteriophage T4 head. Adv Virus Res 82:119\u2013153","journal-title":"Adv Virus Res"},{"issue":"16","key":"15_CR8","doi-asserted-by":"publisher","first-page":"6003","DOI":"10.1073\/pnas.0400444101","volume":"101","author":"A Fokine","year":"2004","unstructured":"Fokine A et al (2004) Molecular architecture of the prolate head of bacteriophage T4. Proc Natl Acad Sci U S A 101(16):6003\u20136008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"15_CR9","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/S0022-2836(77)80088-0","volume":"109","author":"T Ishii","year":"1977","unstructured":"Ishii T, Yanagida M (1977) The two dispensable structural proteins (soc and hoc) of the T4 phage capsid; their purification and properties, isolation and characterization of the defective mutants, and their binding with the defective heads in vitro. J Mol Biol 109(4):487\u2013514","journal-title":"J Mol Biol"},{"issue":"4","key":"15_CR10","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.jmb.2009.10.007","volume":"395","author":"L Qin","year":"2010","unstructured":"Qin L, Fokine A, O'Donnell E, Rao VB, Rossmann MG (2010) Structure of the small outer capsid protein, Soc: a clamp for stabilizing capsids of T4-like phages. J Mol Biol 395(4):728\u2013741","journal-title":"J Mol Biol"},{"issue":"2","key":"15_CR11","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.jmb.2006.08.049","volume":"363","author":"Q Li","year":"2006","unstructured":"Li Q, Shivachandra SB, Leppla SH, Rao VB (2006) Bacteriophage T4 capsid: a unique platform for efficient surface assembly of macromolecular complexes. J Mol Biol 363(2):577\u2013588","journal-title":"J Mol Biol"},{"issue":"5","key":"15_CR12","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.jmb.2007.05.008","volume":"370","author":"Q Li","year":"2007","unstructured":"Li Q, Shivachandra SB, Zhang Z, Rao VB (2007) Assembly of the small outer capsid protein, Soc, on bacteriophage T4: a novel system for high density display of multiple large anthrax toxins and foreign proteins on phage capsid. J Mol Biol 370(5):1006\u20131019","journal-title":"J Mol Biol"},{"issue":"10","key":"15_CR13","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.3201\/eid0810.020332","volume":"8","author":"VP Hsu","year":"2002","unstructured":"Hsu VP et al (2002) Opening a bacillus anthracis-containing envelope, Capitol Hill, Washington, D.C.: the public health response. Emerg Infect Dis 8(10):1039\u20131043","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"15_CR14","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1086\/510312","volume":"195","author":"DL Doolan","year":"2007","unstructured":"Doolan DL et al (2007) The US capitol bioterrorism anthrax exposures: clinical epidemiological and immunological characteristics. J Infect Dis 195(2):174\u2013184","journal-title":"J Infect Dis"},{"key":"15_CR15","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1146\/annurev-micro-091014-104523","volume":"69","author":"M Moayeri","year":"2015","unstructured":"Moayeri M, Leppla SH, Vrentas C, Pomerantsev AP, Liu S (2015) Anthrax pathogenesis. Annu Rev Microbiol 69:185\u2013208","journal-title":"Annu Rev Microbiol"},{"key":"15_CR16","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.3389\/fmicb.2015.01009","volume":"6","author":"ED Williamson","year":"2015","unstructured":"Williamson ED, Dyson EH (2015) Anthrax prophylaxis: recent advances and future directions. Front Microbiol 6:1009","journal-title":"Front Microbiol"},{"issue":"5","key":"15_CR17","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.vaccine.2010.11.049","volume":"29","author":"M Rao","year":"2011","unstructured":"Rao M et al (2011) Highly effective generic adjuvant systems for orphan or poverty-related vaccines. Vaccine 29(5):873\u2013877","journal-title":"Vaccine"},{"issue":"1","key":"15_CR18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1128\/CVI.05376-11","volume":"19","author":"KK Peachman","year":"2012","unstructured":"Peachman KK et al (2012) Anthrax vaccine antigen-adjuvant formulations completely protect New Zealand white rabbits against challenge with Bacillus anthracis Ames strain spores. Clin Vaccine Immunol 19(1):11\u201316","journal-title":"Clin Vaccine Immunol"},{"issue":"19\u201320","key":"15_CR19","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1007\/s00018-006-6312-3","volume":"63","author":"A Scorpio","year":"2006","unstructured":"Scorpio A, Blank TE, Day WA, Chabot DJ (2006) Anthrax vaccines: pasteur to the present. Cell Mol Life Sci 63(19\u201320):2237\u20132248","journal-title":"Cell Mol Life Sci"},{"issue":"8","key":"15_CR20","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1586\/14760584.2013.814860","volume":"12","author":"M Kaur","year":"2013","unstructured":"Kaur M, Singh S, Bhatnagar R (2013) Anthrax vaccines: present status and future prospects. Expert Rev Vaccines 12(8):955\u2013970","journal-title":"Expert Rev Vaccines"},{"issue":"1","key":"15_CR21","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1086\/523578","volume":"46","author":"JD Grabenstein","year":"2008","unstructured":"Grabenstein JD (2008) Vaccines: countering anthrax: vaccines and immunoglobulins. Clin Infect Dis 46(1):129\u2013136","journal-title":"Clin Infect Dis"},{"issue":"7","key":"15_CR22","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/j.vaccine.2006.10.010","volume":"25","author":"SB Shivachandra","year":"2007","unstructured":"Shivachandra SB et al (2007) Multicomponent anthrax toxin display and delivery using bacteriophage T4. Vaccine 25(7):1225\u20131235","journal-title":"Vaccine"},{"issue":"2","key":"15_CR23","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1128\/CVI.05556-11","volume":"19","author":"JA Bellanti","year":"2012","unstructured":"Bellanti JA et al (2012) Phase 1 study of a recombinant mutant protective antigen of Bacillus anthracis. Clin Vaccine Immunol 19(2):140\u2013145","journal-title":"Clin Vaccine Immunol"},{"issue":"1","key":"15_CR24","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1128\/IAI.74.1.794-797.2006","volume":"74","author":"KK Peachman","year":"2006","unstructured":"Peachman KK et al (2006) Correlation between lethal toxin-neutralizing antibody titers and protection from intranasal challenge with Bacillus anthracis Ames strain spores in mice after transcutaneous immunization with recombinant anthrax protective antigen. Infect Immun 74(1):794\u2013797","journal-title":"Infect Immun"}],"container-title":["Methods in Molecular Biology","Recombinant Virus Vaccines"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-6869-5_15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T02:00:57Z","timestamp":1558058457000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-6869-5_15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"ISBN":["9781493968671","9781493968695"],"references-count":24,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-6869-5_15","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]},"assertion":[{"value":"4 April 2017","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}